Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KDM3A pseudogene 1 (KDM3AP1) is referenced as a pseudogene related to the validated protein-coding gene KDM3A. There is no evidence it encodes a functional protein or acts as a molecular target relevant for drug design, biomarker development, or mechanistic studies in cell biology. Most scientific and clinical literature refers to KDM3A (Lysine demethylase 3A), a histone demethylase that specifically demethylates histone H3 lysine 9 (H3K9me1/2) and regulates gene expression affecting androgen receptor signaling, cell proliferation, metabolism, and cancer progression[3][4][1]. In contrast, "KDM3A pseudogene 1" is either an uncharacterized genetic locus, a noncoding sequence, or an annotation error, with no evidence for canonical function, disease association, drug interaction, or biological role. For research and therapeutic targeting, KDM3A should be distinguished from any pseudogene annotations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KDM3A pseudogene 1 (KDM3AP1).